iBET collaboration with its Industrial Partner PBS is now out!
27.05.2013"Comparison Of The Novel PBS Air-Wheel Bioreactor Against The Traditional Stirred-Tank Bioreactor In Microcarrier Applications"
Entrevista com Luis Mesquita Dias, Director-Geral da RAR/Vitacress e Vice-Presidente do iBET ao seminário Sol
03.05.2013"Um dos projectos em discussão com o iBET, de que somos sócios, é o da durabilidade das folhas e o que há a fazer em termos de manipulação, desenvolvimento de sementes e condições de logística"
The Biodiesel project led by SOVENA Oilseeds was successfully completed
29.04.2013This project was a collaboration between SOVENA Oilseeds and the iBET–ASU team with the aim of developing fast analysis methods during routine quality control of production.
iBET Food & Wellness will be present at Alimentaria & Horexpo Lisboa 2013
09.04.2013The International Food, Hospitality and Technology for Food and Drinks Industry Exhibition will take place in Lisbon from the 14th-17th April at FIL-Parque das Nações.
Press Release: March Edition of iBET's Facts & Figures
03.04.2013A new edition of iBET's Facts&Figures is now available. Check it out and get informed on the latest iBET news.
Pontin and Reptin keep attracting attention
03.04.2013iBET and ITQB researchers Pedro Matias, Tiago Bandeiras and Sara Silva, presented their structural work on Pontin and its complex with Reptin at an International Workshop held in Bordeaux, France
The Animal Cell Technology Unit of iBET is partner in the recently awarded SpeCCC Project, funded by the European Union 7th Framework Program
03.04.2013The aim of SpeCCC is to develop a fully functional liver microtissue for toxicity testing, drug discovery, drug biotransformation and ultimately bioreactor component of a Bioartificial Liver (BAL)
iBET and ITQB Researcher, Ana Barbas is one of the two Terry Fox Grants 2012 awardees for Cancer Research
03.04.2013This grant will be used generate and evaluate function blocking antibodies against a ligand of the Notch-signalling pathway, as a potential therapeutic for Breast Cancer treatment.
iBET and AbbVie have just enrolled in a new collaboration
07.03.2013This new collaboration will be focusing on the development and evaluation of improved in vitro / ex vivo models for lung cancer research
iBET – ITQB SEMINAR: February 27th, 10h15m, ITQB Auditorium
26.02.2013"Biophysical Methods in Drug Discovery: Combination is Key - The Project Kinetics for Drug Discovery" by Dr. Matthias Frech, Director Molecular Interactions & Biophysics at MERCK KGaA